We have an exciting opportunity to join the McShane Research Group in the Department of Paediatrics as our Adult Clinical Research Fellow.
You will be working in a small clinical team working on a study aimed at understanding more about COVID 19 disease and the immune responses to SARS-CoV2 and will play an important role in the contribution of effective vaccine and treatment development, as well as for effective public health management.
You will be responsible for planning, directing and undertaking clinical delivery of the research work and provide technical advice and training for research staff relevant to implementation of the research. Responsibilities will also include clinical governance leadership, and collaboration in the preparation of clinical reports and journal articles, and with international stakeholders and funders.
You will be working in a growing department within the Medical Sciences Division. The Department of Paediatrics is a world leader in child health research and hosts internationally renowned research programmes in drug development, gastroenterology, haematology, HIV, immunology, neuroimaging, neuromuscular diseases and vaccinology. The McShane Research Group, under the lead of Professor Helen McShane, conducts research in human challenge models for vaccine development and successfully published their latest SARS CoV2 human challenge work (see Jackson et al, Lancet Microbe 2024).
This position is offered full-time on a fixed-term contract initially for 12 months, with the possibility to extend, provided further external funding is available. Part-time applications may be considered (with a minimum of 60% FTE).
You will have a medical degree, with proven and demonstrable interpersonal skills. You will have full GMC registration with licence to practice or evidence of having applied for full GMC registration and be willing to cover clinical visits on an on-call rota basis including weekend and overnight cover. You will have highly effective verbal and written communication skills with all level of staff and an ability to operate effectively in a demanding and busy research environment. The successful candidate would, ideally, start in role in February 2025.